STAT+: Allogene CEO David Chang stepping down

Meghana Keshavan· May 29, 2026 · 1:14 PM UTC ·1 min read · 0 reactions · 0 comments · 55 views

Pfizer invests billions to buy Chinese drugs, WHO maps experimental response to Ebola outbreak, and other biotech news from The Readout

About this source

STAT News files mainly under health. We currently carry 235 of its stories.

All STAT News coverage →

Original article

STAT News · Meghana Keshavan

Read full at STAT News →

Story provenance

Source · retrieval · rights · ranking — open for full record

inspect →

Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.

Record

Original publisher	STAT News
Canonical URL	https://www.statnews.com/2026/05/29/biotech-news-allogene-ceo-david-chang-steps-down/?utm_campaign=rss
Publication time	Fri, 29 May 2026 13:14:33 +0000
Retrieval time	2026-05-29T13:20:00.413Z
Last seen	2026-05-29T13:20:00.413Z
Headline source	Publisher (no WeSearch rewrite)
Excerpt source	publisher body
Excerpt method	First ~120 words (~800 chars) of extracted publisher body, fair-use limited.
Summary	None yet
Summary source text	contentText
Citation coverage	No WeSearch summary has been generated for this story yet.
Cluster	NAck-3eW8qxk
Cluster logic	Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison.
Ranking reason	Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking.
Publisher visit	Yes — open original
Substitutes article?	No — link-out required for full text

Rights status (four layers)

Publisher-declared

No publisher-confirmed rights record for this source yet.

Machine-readable

No source-specific machine-readable restriction detected beyond the public feed.

WeSearch interpretation

WeSearch declared handling (basis: Derived from the published RSS/Atom feed). This is WeSearch policy, not a legal grant on the publisher's behalf.

Unknown

Retrieval and training permissions are not asserted unless the publisher confirms them.

WeSearch handling by dimension

Indexing	May the item be indexed (stored, ranked, made findable)?	Allowed
Snippet	May a short excerpt of the publisher's text be shown?	Allowed
AI summary	May WeSearch generate its own short summary of the article?	Limited
Retrieval / RAG	May the content be exposed for third-party retrieval-augmented generation?	Not asserted
Model training	May the content be used to train AI models?	Not asserted
Commercial reuse	May the content be reused commercially?	Not permitted

Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.

Open original publisher → Source rights JSON → Machine-readable provenance → Rights framework → WESEARCH-STORY-PROVENANCE-V1

Opening excerpt (first ~120 words) tap to expand

Biotech Biotech May 28, 2026 STAT Plus: Biotech veteran Jeremy Levin on why the industry’s future is secure, but American leadership is at risk By Adam Feuerstein, Allison DeAngelis, Elaine Chen, and Ayushi Jha

Excerpt limited to ~120 words for fair-use compliance. The full article is at STAT News.

Anonymous · no account needed

Discussion

0 comments